The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design

被引：0

作者：

Rikke Mette Agesen

Amra Ciric Alibegovic

Henrik Ullits Andersen

Henning Beck-Nielsen

Peter Gustenhoff

Troels Krarup Hansen

Christoffer Hedetoft

Tonny Jensen

Claus Bogh Juhl

Susanne Søgaard Lerche

Kirsten Nørgaard

Hans-Henrik Parving

Lise Tarnow

Birger Thorsteinsson

Ulrik Pedersen-Bjergaard

机构：

[1] Nordsjællands Hospital,Department of Endocrinology and Nephrology

[2] Steno Diabetes Center Copenhagen,Department of Endocrinology M

[3] Odense University Hospital,Faculty of Health Sciences

[4] University of Southern Denmark,Department of Endocrinology

[5] Aalborg University Hospital,Department of Medical Endocrinology

[6] Steno Diabetes Center Aarhus,Department of Diabetes and Hormonal Diseases

[7] Health,Department of Endocrinology

[8] University of Aarhus,Department of Clinical Research

[9] Department of Internal Medicine,Faculty of Health and Medical Sciences

[10] Copenhagen University Hospital (Rigshospitalet),undefined

[11] Department of Medicine,undefined

[12] Sydvestjysk Sygehus,undefined

[13] Lillebælt Hospital Kolding,undefined

[14] Hvidovre University Hospital,undefined

[15] Nordsjællands Hospital,undefined

[16] Steno Diabetes Center Sjaelland,undefined

[17] University of Copenhagen,undefined

来源：

BMC Endocrine Disorders | / 19卷

关键词：

Type 1 diabetes; Nocturnal hypoglycaemia; Severe hypoglycaemia; Insulin degludec; Insulin glargine; RCT;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
Agesen, Rikke Mette
Alibegovic, Amra Ciric
Andersen, Henrik Ullits
Beck-Nielsen, Henning
Gustenhoff, Peter
Hansen, Troels Krarup
Hedetoft, Christoffer
Jensen, Tonny
Juhl, Claus Bogh
Lerche, Susanne Sogaard
Norgaard, Kirsten
Parving, Hans-Henrik
Tarnow, Lise
Thorsteinsson, Birger
Pedersen-Bjergaard, Ulrik
BMC ENDOCRINE DISORDERS, 2019, 19 (1)
[2] Nocturnal hypoglycaemia with insulin degludec and glargine U100 in patients with type 1 diabetes prone to severe nocturnal hypoglycaemia (HypoDEG): a CGM substudy
Brosen, J.
Agesen, R. M.
Alibegovic, A. C.
Andersen, H. U.
Beck-Nielsen, H.
Gustenhoff, P.
Hansen, T. K.
Hedetoft, C.
Jensen, T.
Juhl, C. B.
Lerche, S. S.
Norgaard, K.
Parving, H. -H.
Tarnow, L.
Pedersen-Bjergaard, U.
DIABETOLOGIA, 2020, 63 (SUPPL 1) : S356 - S356
[3] Effect of Insulin Degludec on Frequency of Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia: The HypoDeg Trial
Agesen, Rikke M.
Alibegovic, Amra Ciric
Andersen, Henrik U.
Gustenhoff, Peter
Hansen, Troels K.
Jensen, Tonny, Sr.
Juhl, Claus B.
Jensen, Andreas K.
Lerche, Susanne
Norgaard, Kirsten
Parving, Hans-Henrik D.
Sorensen, Anne L.
Tarnow, Lise
Thorsteinsson, Birger
Pedersen-Bjergaard, Ulrik
DIABETES, 2020, 69
[4] Effect of insulin degludec vs insulin glargine U100 on occurrence of nocturnal hypoglycaemia assessed by plasma glucose profiles in people with type 1 diabetes: HypoDeg trial
Brosen, J. M. B.
Agesen, R. M.
Kristensen, P. L.
Alibegovic, A. C.
Andersen, H. U.
Beck-Nielsen, H.
Gustenhoff, P.
Hedetoft, C.
Jensen, T.
Juhl, C. B.
Lerche, S. S.
Norgaard, K.
Parving, H. -H.
Tarnow, L.
Pedersen-Bjergaard, U.
DIABETOLOGIA, 2021, 64 (SUPPL 1) : 270 - 271
[5] The effect on insulin analogues on the risk of severe hypoglycaemia in patients with type 1 diabetes and recurrent severe hypoglycaemia: the HypoAna trial
Pedersen-Bjergaard, U.
Kristensen, P. L.
Beck-Nielsen, H.
Norgaard, K.
Perrild, H.
Christiansen, J. S.
Jensen, T.
Hougaard, P.
Parving, H-H.
Thorsteinsson, B.
Tarnow, L.
DIABETOLOGIA, 2013, 56 : S84 - S84
[6] Risk of nocturnal hypoglycaemia in children with type 1 diabetes mellitus treated with insulin glargine
Emelyanov, Andrey
Kuraeva, Tamara
Cherbacheva, Lyudmila
Andrianova, Ekaterina
Titovich, Elena
Maxomova, Valentina
HORMONE RESEARCH, 2006, 65 : 60 - 60
[7] A two year randomised trial: improved glycaemic control and lower risk of nocturnal hypoglycaemia with insulin degludec compared with insulin glargine in Type 1 diabetes
Russell-Jones, D. L.
Heller, S.
Hansen, C. T.
Chang, D.
Bode, B.
DIABETIC MEDICINE, 2013, 30 : 74 - 74
[8] Reduced nocturnal hypoglycaemia with insulin degludec vs insulin glargine: a two year trial in Type 2 diabetes
Cariou, B.
Rodbard, H.
Zinman, B.
Philis-Tsimikas, A.
Handlesman, Y.
Skoth, T. V.
Chu, P-L
Mathieu, C.
DIABETIC MEDICINE, 2013, 30 : 55 - 55
[9] COMPARISON OF INSULIN DEGLUDEC AND GLARGINE U100 IN PATIENTS WITH TYPE 1 DIABETES PRONE TO SEVERE NOCTURNAL HYPOGLYCAEMIA
Agesen, R.
Alibegovic, A.
Andersen, H.
Beck-Nielsen, H.
Gustenhoff, P.
Hansen, T.
Hedetoft, C.
Jensen, T.
Juhl, C.
Kryger, A.
Lerche, S.
Norgaard, K.
Parving, H. -H.
Sorensen, A.
Tarnow, L.
Thorsteinsson, B.
Pedersen-Bjergaard, U.
DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A93 - A94
[10] Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial
Pedersen-Bjergaard, Ulrik
Agesen, Rikke M.
Brosen, Julie M. B.
Alibegovic, Amra C.
Andersen, Henrik U.
Beck-Nielsen, Henning
Gustenhoff, Peter
Hansen, Troels K.
Hedetoft, Christoffer
Jensen, Tonny J.
Juhl, Claus B.
Jensen, Andreas K.
Lerche, Susanne S.
Norgaard, Kirsten
Parving, Hans-Henrik
Sorensen, Anne L.
Tarnow, Lise
Thorsteinsson, Birger
DIABETES OBESITY & METABOLISM, 2022, 24 (02): : 257 - 267

← 1 2 3 4 5 →